Arthur T. Sands
2006 - Lexicon Pharmaceuticals
In 2006, Arthur T. Sands earned a total compensation of $1.9M as President, Chief Executive Officer and Director at Lexicon Pharmaceuticals.
Compensation breakdown
| Bonus | $300,000 |
|---|---|
| Option Awards | $792,267 |
| Salary | $473,000 |
| Other | $373,466 |
| Total | $1,938,733 |
Sands received $792.3K in option awards, accounting for 41% of the total pay in 2006.
Sands also received $300K in bonus, $473K in salary and $373.5K in other compensation.
Rankings
In 2006, Arthur T. Sands' compensation ranked 1,769th out of 7,022 executives tracked by ExecPay. In other words, Sands earned more than 74.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,769 out of 7,022 | 75th |
Division Manufacturing | 547 out of 2,413 | 77th |
Major group Chemicals And Allied Products | 101 out of 673 | 85th |
Industry group Drugs | 54 out of 518 | 90th |
Industry Pharmaceutical Preparations | 44 out of 355 | 88th |
Source: SEC filing on March 13, 2009.
Sands' colleagues
We found four more compensation records of executives who worked with Arthur T. Sands at Lexicon Pharmaceuticals in 2006.
News
Nurix Therapeutics CEO Arthur Sands' 2023 pay falls 54% to $4.4M
March 27, 2024
Nurix Therapeutics CEO Arthur Sands' 2022 pay jumps 97% to $9.4M
March 24, 2023
Nurix Therapeutics COO Stefani Wolff receives $7.1M in 2021
March 25, 2022
Nurix Therapeutics CEO Arthur Sands' 2020 pay jumps 1,041% to $17M
March 25, 2021